IFLR1000

Mediclinic/Al Noor Hospitals £1.4 billion merger

15/2/2016
Merger
Select tab

£ 1.4 billion

$ 1.743 billion

Completed

15/2/2016

Overview:

  • Mediclinic International has undertaken a merger via reverse takeover with Al Noor Hospitals Group.
  • The combined group will maintain its listing on the LSE as well as a secondary listing on the Johannesburg Stock Exchange.
  • Mediclinic is a private healthcare group headquartered in South Africa.
  • Al Noor is a private integrated healthcare provider in Abu Dhabi.
  • For Mediclinic, Slaughter and May handled the UK corporate advice alongside Cliffe Dekker on South African aspects while DLA Piper handled aspects of the financing and the real estate matters.
  • Rothschild acted as financial adviser and sponsor. Jefferies also acted as sponsor.
  • Remgro, a South African investment holding company, was a major shareholder in Mediclinic.

Sam Duke - Editor

Jurisdictions:

South Africa
United Kingdom
United Arab Emirates

Deal type:

Merger

Practice area:

M&A

Industry sector:

Healthcare

Firms:
Ashurst

Party: Jefferies Financial (Financial adviser, Sponsor)

Party: N M Rothschild & Sons (Financial adviser, Sponsor)

Lawyer: Tom Mercer

Cliffe Dekker Hofmeyr

Party: Mediclinic International (Merger party)

Lawyers: Francis Newham, Peter Hesseling, Susan Meyer, Yaniv Kleitman

Cravath Swaine & Moore

Party: Remgro (Shareholder)

Lawyer: George Stephanakis

DLA Piper

Party: Mediclinic International (Merger party)

ENSafrica

Party: Remgro (Shareholder)

Lawyer: Michael Katz

Linklaters

Party: Al Noor Hospitals Group (Merger party)

Lawyers: Annabel Parry, David Martin, Iain Fenn, Jason Manketo, Kevin Hillis

Slaughter and May

Party: Mediclinic International (Merger party)

Lawyers: Ed Fife, Robert Innes

Webber Wentzel

Party: Al Noor Hospitals Group (Merger party)

Lawyers: Annabel Parry, Annabel Parry, Kevin Hillis, Kevin Hillis

Related deals